Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Translated into:
Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Dorzolamide Hydrochloride is a carbonic anhydrase inhibitor API widely used for treatment of glaucoma and ocular hypertension. Dorzolamide Hydrochloride inhibits carbonic anhydrase in the ciliary body by which it reduces aqueous humor production and lowers intraocular pressure [IOP]. When IOP is reduced, optic nerve is protected, and vision is preserved making Dorzolamide Hydrochloride a key component in both monotherapy and fixed dose combination treatment. Dorzolamide is administered topically and has good safety profile with targeted ocular action and systemic absorption is very low which makes it first choice for glaucoma therapy.
We export our APIs from India to international markets like Asia, Africa, the Middle East, Europe and America.
Welox Pharma Private Limited is the leading manufacturer of APIs (Active Pharmaceutical Ingredients) and Intermediates offering high-quality products with the highest levels of compliance and our API products are trusted by pharmaceutical companies in over 90 countries, reflecting our global footprint and reputation.
Welox Pharma Private Limited is a fully integrated company involved in the complete lifecycle of Active Pharmaceutical Ingredients (API), including the development, production, and sales of Active Pharmaceutical Ingredients (API), High Potency API, and API intermediates.
Trade Information :
Export Licence: Own Licence
Export Licence Number: AAECW2455N
Export Mode: By Sea / By Air
Incoterms: CNF, CIF, CIP, FOB, EXW
Payment Terms: Bank Transfer
Nearest Port : Ahmedabad Airport / Hazira / Nhava Sheva / Bombay Airport